These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4565168)

  • 1. [Studies on differing complement-fixing properties of antinuclear antibodies in the nephropathy of systemic lupus erythematosus].
    Tojo T; Miyachi K; Homma M
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):621-30. PubMed ID: 4565168
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic factors and clinical activity in systemic lupus erythematosus.
    Schur PH; Sandson J
    N Engl J Med; 1968 Mar; 278(10):533-8. PubMed ID: 4866347
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulin classes and IgG subclasses of human antinuclear antibodies. A correlation of complement fixation and the nephritis of systemic lupus erythematosus.
    Puritz EM; Yount WJ; Newell M; Utsinger PD
    Clin Immunol Immunopathol; 1973 Nov; 2(1):98-113. PubMed ID: 4149506
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lupus nephritis--multiplicity of immunoglobulin G antinuclear antibody].
    Tojo T; Honma M
    Nihon Rinsho; 1972 Sep; 30(9):1979-85. PubMed ID: 4568206
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis.
    Sontheimer RD; Gilliam JN
    Clin Immunol Immunopathol; 1978 Aug; 10(4):459-67. PubMed ID: 308429
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of immune deposits in the skin in SLE.
    Wertheimer D; Barland P
    Arthritis Rheum; 1976; 19(6):1249-55. PubMed ID: 793599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephritis and the presence of antiribonucleoprotein antibodies in disseminated lupus erythematosus in children and adolescents].
    Lapointe ND; Carrenö-Perrez L; Pelletier M; Déom P; Robitaille P
    Union Med Can; 1985 Jun; 114(6):490-2. PubMed ID: 3875176
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus.
    Brunner CM; Horwitz DA; Shann MK; Sturgill BA; Davis JS
    Am J Med; 1973 Aug; 55(2):249-54. PubMed ID: 4579077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiamphenicol as an immunosuppressant in active systemic lupus erythematosus with nephritis.
    Richmond DE
    Aust N Z J Med; 1979 Dec; 9(6):670-5. PubMed ID: 317000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological studies concerning the nephritis of systemic lupus erythematosus.
    Koffler D; Schur PH; Kunkel HG
    J Exp Med; 1967 Oct; 126(4):607-24. PubMed ID: 4168098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-fixing activity of antinuclear antibodies induced by procaine amide treatment.
    Klajman A; Farkas R; Ben-Efraim S
    Isr J Med Sci; 1973 May; 9(5):627-30. PubMed ID: 4123966
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.
    Rubin RL; Teodorescu M; Beutner EH; Plunkett RW
    Lupus; 2004; 13(4):249-56. PubMed ID: 15176661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of antinuclear antibodies with hypocomplementemia.
    Morris JL; Zizic TM; Shulman LE; Stevens MB
    Johns Hopkins Med J; 1973 Dec; 133(6):321-8. PubMed ID: 4543273
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG antibodies to double-stranded DNA in systemic lupus erythematosus sera. Independent variation of complement fixing activity and total antibody content.
    Beaulieu A; Quismorio FP; Friou GJ; Vayuvegula B; Mirick G
    Arthritis Rheum; 1979 Jun; 22(6):565-70. PubMed ID: 378238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.
    Mackay IR; Robson G; Chan D
    Australas Ann Med; 1970 May; 19(2):123-30. PubMed ID: 4194493
    [No Abstract]   [Full Text] [Related]  

  • 18. [Binding of complement by anti-native desoxyribonucleic acid antibodies in systemic lupus erythematosus].
    Youinou P; Le Goff P; Jouquan J; Cledes J; Pennec Y; Mottier D; Abgrall JF; Tandé D; Cam P; Le Menn G
    Presse Med; 1985 Apr; 14(16):875-8. PubMed ID: 3158921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lupus nephritis: elution studies and the role of circulating antinuclear factors].
    Cossio PM; Arana RM; García Morteo O
    Medicina (B Aires); 1970; 30(4):372-9. PubMed ID: 4098883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.